Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandra Agudo Fernández"'
Autor:
Carlos Castaño Milla, Lorena Sancho Del Val, José Antonio Olmos Jerez, Sandra Agudo-Fernández, Isabel Calvo Morillas, Ana González Blanco
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:2794-2802
BACKGROUND AND AIM Atrial fibrillation is a major cause of death and disability due to stroke. Vitamin K antagonist drugs are effective for prevention, but they have a narrow therapeutic range and multiple pharmacological interactions. In recent year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c09b511e3cf3f72ff8b85d98d43af7
https://doi.org/10.1111/jgh.15547
https://doi.org/10.1111/jgh.15547
Publikováno v:
Gastroenterología y Hepatología. 41:483-489
Resumen Objetivo La resistencia de Helicobacter pylori a los antibioticos es un problema creciente en nuestro medio y es necesario mejorar las tasas de erradicacion. La cuadruple terapia con bismuto se ha considerado el tratamiento de primera o segun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba6d891aef32e31ebf8e43b6e1120c50
https://doi.org/10.1016/j.gastrohep.2018.05.016
https://doi.org/10.1016/j.gastrohep.2018.05.016
Publikováno v:
Gastroenterología y Hepatología (English Edition). 41:483-489
Objective The resistance of Helicobacter pylori to antibiotics is a growing problem in Spain and eradication rates must be improved. The new Spanish consensus considers quadruple therapy with bismuth as first- or second-line therapy. This study evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b7a980a92691fbaa3765d70e79c53a5
https://doi.org/10.1016/j.gastre.2018.05.017
https://doi.org/10.1016/j.gastre.2018.05.017
Autor:
Lourdes García Bermúdez, Beatriz Carrascosa Aguilar, Isabel Núñez, Sandra Sánchez Lozano, María Jesús Izquierdo, Pilar Lasala López, Isabel Mariño Pfeiffer, Cristina Murillo, Mercedes Martínez Abad, Conrado M Fernández Rodríguez, Gil Rodriguez Caravaca, Cristina Guisado Pérez, Guadalupe Montes Ramírez, Noelia Villafranca Ortega, Sandra Agudo Fernández, Maria Luisa García, Francisco Javier Sánchez Jiménez, Susana Berbel León, Paloma López Hermosa Seseña, Isabel Ayuso Hernández, Lourdes Visedo Campillo, Antonia García del Val, Elena López Vega, M. Luisa Castro Pastor, Sònia López, Jesús Zambrano Álvarez, María Espejo
Publikováno v:
Gastroenterología y Hepatología. 39:656-662
Resumen Introduccion La seroprevalencia estimada del VHC en Espana es del 1,7%, cifra que es muy superior en la poblacion con factores de riesgo. Se desconoce cual seria la estrategia de cribado mas eficiente en nuestro pais. Objetivos Estimar la pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13ca4df92746bc506930c37ea0f3a252
https://doi.org/10.1016/j.gastrohep.2016.05.002
https://doi.org/10.1016/j.gastrohep.2016.05.002
Publikováno v:
Gastroenterologia y hepatologia. 41(8)
The resistance of Helicobacter pylori to antibiotics is a growing problem in Spain and eradication rates must be improved. The new Spanish consensus considers quadruple therapy with bismuth as first- or second-line therapy. This study evaluated the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c87802dc5abb0333532cfbc2ff87331
https://pubmed.ncbi.nlm.nih.gov/30041999
https://pubmed.ncbi.nlm.nih.gov/30041999
Autor:
Sònia López, Patricia Sanmartin Fenollera, Sandra Agudo Fernández, María Luisa Gutiérrez García, María Dolores Martín Rios, Conrado M Fernández Rodríguez
Publikováno v:
Gastroenterología y Hepatología. 38:1-6
Hepatitis B virus (HBV) reactivation after chemotherapy regimens is a well-known complication. The incidence and risk factors for HBV reactivation remain to be elucidated. We aimed to determine the incidence and risk factors for HBV reactivation in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cc847cb5d11070aea8772dc475f48d0
https://doi.org/10.1016/j.gastrohep.2014.05.008
https://doi.org/10.1016/j.gastrohep.2014.05.008
Autor:
Guadalupe Montes Ramírez, Susana Berbel León, Francisco Javier Sánchez Jiménez, Lourdes Visedo Campillo, Pilar Lasala López, Mercedes Martínez Abad, Elena López Vega, Cristina Murillo, Lourdes García Bermúdez, Noelia Villafranca Ortega, Beatriz Carrascosa Aguilar, María Jesús Izquierdo, Paloma López Hermosa Seseña, Sandra Sánchez Lozano, María Espejo, Isabel Núñez, Sandra Agudo Fernández, Sònia López, Cristina Guisado Pérez, Jesús Zambrano Álvarez, Isabel Mariño Pfeiffer, Conrado M Fernández Rodríguez, Gil Rodriguez Caravaca, Maria Luisa García, Isabel Ayuso Hernández, Antonia García del Val, M. Luisa Castro Pastor
Publikováno v:
Gastroenterologia y hepatologia. 39(10)
Introduction The estimated seroprevalence of hepatitis C virus (HCV) in Spain is 1.7%, but is much higher in the at-risk population. The most efficient national screening strategy is unclear. Aims To estimate the prevalence of HCV among the at-risk p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509c09a7ff0fba3c213ebc50dc13c2f4
https://pubmed.ncbi.nlm.nih.gov/27417563
https://pubmed.ncbi.nlm.nih.gov/27417563
Autor:
Sandra Agudo Fernández
Publikováno v:
Gastroenterología y Hepatología. 38:108-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c72103eaf005c60e577935b80fb19d6
https://doi.org/10.1016/j.gastrohep.2014.05.006
https://doi.org/10.1016/j.gastrohep.2014.05.006